NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Tuesday reported a loss of $8.7 million in its second quarter.

The Newark, California-based company said it had a loss of 41 cents per share.

The biopharmaceutical company posted revenue of $11.7 million in the period.

Protagonist Therapeutics shares have fallen 47 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $10.99, a drop of slightly more than 5 percent in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on PTGX at

blog comments powered by Disqus